Unlike the prior studies that implicate altered extracellular matrix (ECM) remodeling as the source of MPS cardiac disease (52–54), in MLII, the downstream effects of spurious cathepsin activity are largely driven by altered growth factor signaling. This evidence concerns the gene CTSS and heart disorder.